Rexahn's ArchexinTM Recognized as One of Windhover's Top 10 Most Promising Oncology Products Nov 9, 2009
New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn's Archexin(TM) as Potent Inhibitor of Human Cancer Cell Growth Oct 22, 2009
Rexahn Reports Positive Top-line Phase IIa Data for SerdaxinTM in Patients with Major Depressive Disorder (MDD) Oct 19, 2009
Rexahn Pharmaceuticals to Present at the 8th Annual Bio Investor Forum on October 29, 2009 Oct 15, 2009
Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement Sep 17, 2009
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference on September 10, 2009 Sep 3, 2009